Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study (vol 26, pg 4311, 2008)

[摘要]：

[全文传递流程]：

一般上传文献全文的时限在1个工作日内